Kringle Pharma
Japan - IbarakiPharmaceutical
Focus: Kringle Pharma is a Japan-based biologics specialist headquartered in Ibaraki focused on regenerative medicine and tissue repair applications. The company operates with a lean pipeline across early-to-mid stage development programs.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Kringle Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Kringle Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
KP-100IT
Spinal Cord InjuriesClinical Trials (1)
NCT02193334Phase I/II Study of KP-100IT in Acute Spinal Cord Injury
Phase 1/2Help build intelligence for Kringle Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.